SCHEMBL1824501

SCHEMBL1824501

COC(=O)CC(NC(=O)OC(C)(C)C)c1ccc(OS(=O)(=O)c2ccccc2C)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.47
NPSR1 Q6W5P4 6/20 0.42
LMNA P02545 5/20 0.42
HPGD P15428 5/20 0.42
HTT P42858 5/20 0.42
ALDH1A1 P00352 5/20 0.42
PKM P14618 4/20 0.42
HSD17B10 Q99714 3/20 0.42
TSHR P16473 3/20 0.42
MAPT P10636 3/20 0.42
TP53 P04637 2/20 0.42
AGTR1 P30556 1/20 0.42
RAB9A P51151 1/20 0.42
KMT2A Q03164 6/20 0.41
MEN1 O00255 5/20 0.41
XBP1 P17861 3/20 0.41
JAK2 O60674 3/20 0.41
S1PR4 O95977 2/20 0.41
ALOX15 P16050 2/20 0.41
S1PR1 P21453 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1827771 0.88 ALDH1A1 (0.46) POLBNPSR1LMNAHPGDHTT
SCHEMBL1820857 0.84 P2RX7 (0.44) NPSR1LMNAHPGDHTTALDH1A1
SCHEMBL1823945 0.84 HTT (0.40) POLBNPSR1LMNAHPGDHTT
SCHEMBL1826490 0.82 ABCB1 (0.50) NPSR1LMNAHPGDHTTALDH1A1
SCHEMBL1826039 0.82 POLB (0.50) POLBNPSR1LMNAHPGDHTT
SCHEMBL1827338 0.81 TSHR (0.44) NPSR1LMNAHPGDHTTALDH1A1
SCHEMBL2367224 0.80 NPSR1 (0.47) POLBNPSR1HPGDALDH1A1KMT2A
SCHEMBL31633773 0.80 CTSK (0.52) POLBNPSR1LMNAHPGDHTT
SCHEMBL1573513 0.80 CTSK (0.52) POLBNPSR1LMNAHPGDHTT
SCHEMBL5862217 0.80 CTSK (0.52) POLBNPSR1LMNAHPGDHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2161254-B1 Intermediate for preparing a biaryl compound SUMITOMO CHEMICAL CO (JP) 2014-08-13 EP disclosed
EP-1481967-B1 PROCESS FOR THE PREPARATION OF BIARYL COMPOUNDS SUMITOMO CHEMICAL CO (JP) 2011-05-04 EP disclosed
US-7714157-B2 Process for preparing a biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-05-11 US disclosed
EP-2161254-A1 Intermediate for preparing a biaryl compound Sumitomo Chemical Company, Limited (JP) 2010-03-10 EP disclosed
US-20070270603-A1 Process for preparing a biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED 2007-11-22 US disclosed
US-7271280-B2 Process for preparing a biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-09-18 US disclosed
EP-1481967-A1 PROCESS FOR THE PREPARATION OF BIARYL COMPOUNDS Sumitomo Chemical Company, Limited (JP) 2004-12-01 EP disclosed
US-20040158093-A1 Process for preparing a biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED 2004-08-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040158093-A1 Process for preparing a biaryl compound CYP1B1, REL, CYP2F1 POLB 1462/4885NPSR1 1107/4885LMNA 1802/4885
US-20070270603-A1 Process for preparing a biaryl compound CYP4A11, CYP4B1, CYP51A1 POLB 1541/4885NPSR1 2245/4885LMNA 1130/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.